A study by researchers from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences have uncovered the underlying mechanism of how Y-box binding protein 1 promotes cancer...
Cross-platform evaluation study demonstrates reproducibility and high detection rate for MiRXES ID3EAL qPCR microRNA (miRNA) profiling platform when used for discovery and validation of blood-based...
Data from collaborative study between MiRXES and Janssen demonstrate how miRNA-based biomarker signatures could lead to potential in early identification and diagnosis of pulmonary hypertension....
Collaborative study between MiRXES Pte Ltd and Actelion Pharmaceuticals Ltd reveals microRNA (miRNA) biomarker signatures have the potential to develop into early identification and diagnosis of...
Researchers from Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing discover miRNA in honeysuckle decoction (HD) can directly target...
Study led by Zhang Chen-Yu from the Nanjing University School of Life Sciences, China finds the molecular mechanism of SIDT1 in mediating the uptake of dietary and orally administered microRNAs...
Researchers in Daegu Gyeongbuk Institute of Science and Technology found environmental cues trigger microRNAs to regulate the development and distribution of tiny pores involved in photosynthesis in...
Front runners Singapore-based biotech company, MiRXES, National University of Singapore (NUS) and Diagnostics Development (DxD) Hub of the Agency for Science, Technology and Research (A*STAR) launch...
Local Singapore-based biotech company, MiRXES Pte Ltd, spun off from the Agency for Science, Technology and Research (A*STAR) in Singapore in 2014. Their microRNA research and technology platform...
